戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 olecular testing for Aspergillus in clinical mycology.
2 of routine laboratory performance in medical mycology.
3  improve and streamline the work flow in the mycology and clinical microbiology laboratory.
4 drugs, more training in the field of medical mycology, and better funding for research and provision
5   Growth was detected in all BacT and Bactec mycology bottles, all BacT aerobic bottles, and by termi
6 6 (27%) anaerobic bottles, and 210/216 (97%) mycology bottles.
7 n method developed at the Center for Medical Mycology, Cleveland, Ohio, for testing the susceptibilit
8  testing developed at the Center for Medical Mycology, Cleveland, Ohio.
9                            Of 3,855 positive mycology cultures (yeast, 82%; molds, 18%), 62 (1.6%) we
10 rmine the benefit of a 4-week incubation for mycology cultures, we evaluated all positive cultures du
11 as not been utilized extensively in clinical mycology due to challenges in developing an effective pr
12 , and his interests included plant diseases, mycology, forest insects, white pine blister rust, the m
13                          Research in medical mycology has traditionally been a mix of exciting biolog
14 o alert clinicians and personnel in clinical mycology laboratories of the pathogenicity of this organ
15                 Direct isolation could allow mycology laboratories to more rapidly identify Candida s
16 of yeast species commonly encountered in the mycology laboratory at Mayo Clinic is described here.
17 tion of filamentous fungi encountered in the mycology laboratory at the Mayo Clinic.
18  our routine workflow has revolutionized our mycology laboratory efficiency, with improved accuracy a
19 atophytes commonly encountered in a clinical mycology laboratory-Trichophyton mentagrophytes, Trichop
20 ntification of dermatophytes in the clinical mycology laboratory.
21                  The aerobic, anaerobic, and mycology media for each system were evaluated: Bactec Pl
22 des of simulated candidemia when specialized mycology media were used.
23 on Czapek Dox agar but are absent on routine mycology media, where only chlamydospores are observed.
24 y addresses this issue by evaluating medical mycology OPT and comparing its fungal specimen identific
25 ratories participating in the New York State mycology OPT from 1982 to 1994 were compared with the id
26 at accompany yeast isolates submitted to the Mycology Reference Laboratory (United Kingdom) for eithe
27 riensis were submitted to the United Kingdom Mycology Reference Laboratory for identification.
28 east species submitted to the United Kingdom Mycology Reference Laboratory over a 2-year period.
29 ive isolates of C. albicans submitted to the Mycology Reference Laboratory over a 9-month period.
30 s agents of mucormycosis and referred to the Mycology Reference Laboratory, Bristol, UK, for speciati
31 rphologic classification when performed by a mycology reference laboratory, but a higher rate of mism
32 s are in place for the next phase of medical mycology research: defining the virulence-associated fac
33 icin B and a broad-spectrum triazole pending mycology results) among patients with suspicious wounds.
34  From assistant mycologist in the Section of Mycology to Chief of the Bureau of Plant Industry to Ass

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。